BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6658706)

  • 1. Disposition of human fibrinopeptide A in normal and nephrectomized rabbits.
    Harenberg J; Stehle G; Waibel S; Hermann HJ; Eisenhut M; Zimmermann R
    Thromb Res; 1983 Oct; 32(1):1-13. PubMed ID: 6658706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Turnover of fibrinopeptide A (FPA) in rabbits.
    Ariga T; Oshiba S; Akashi Y; Endoh E; Imai H; Sawai H
    Thromb Res; 1985 Apr; 38(2):137-47. PubMed ID: 4002202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 125I-fibrinogen kinetics and fibrinopeptide A in patients with disseminated neoplasias.
    Mombelli G; Roux A; Haeberli A; Straub PW
    Blood; 1982 Aug; 60(2):381-8. PubMed ID: 7093524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity.
    Nossel HL; Ti M; Kaplan KL; Spanondis K; Soland T; Butler VP
    J Clin Invest; 1976 Nov; 58(5):1136-44. PubMed ID: 993337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biological significance of fibrinopeptide A elevation in the blood].
    Mombelli G; Hofmann V; Straub PW
    Schweiz Med Wochenschr; 1977 Dec; 107(48):1779-81. PubMed ID: 579262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed release of an abnormal fibrinopeptide A from fibrinogen Manchester: effect of the A alpha 16 Arg leads to His substitution upon fibrin monomer polymerization and the immunological crossreactivity of the peptide.
    Lane DA; Southan C; Ireland H; Thompson E; Kehl M; Henschen A
    Br J Haematol; 1983 Apr; 53(4):587-97. PubMed ID: 6830702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinopeptide A in urine from patients with venous thromboembolism, disseminated intravascular coagulation and rheumatoid arthritis--evidence for dephosphorylation and carboxyterminal degradation of the peptide by the kidney.
    Leeksma OC; Meijer-Huizinga F; Stoepman-van Dalen EA; van Aken WG; van Mourik JA
    Thromb Haemost; 1985 Dec; 54(4):792-8. PubMed ID: 4089813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinopeptide A excretion in urine in patients with atherosclerotic artery disease.
    Gallino A; Haeberli A; Straub PW
    Thromb Res; 1985 Jul; 39(2):237-44. PubMed ID: 4024054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A thrombin assay based upon the release of fibrinopeptide A from fibrinogen: definition of a new thrombin unit.
    Lewis SD; Shafer JA
    Thromb Res; 1984 Jul; 35(2):111-20. PubMed ID: 6474412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinopeptide-A in diabetes mellitus. Relation to levels of blood glucose, fibrinogen disappearance, and hemodynamic changes.
    Jones RL
    Diabetes; 1985 Sep; 34(9):836-43. PubMed ID: 4029510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fibrinogen metabolism and plasma fibrinopeptide A in disseminated neoplasms].
    Mombelli G; Roux A; Hofmann V; Straub PW
    Schweiz Med Wochenschr; 1979 Dec; 109(47):1901. PubMed ID: 531571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactoperoxidase iodination of desaminotyrosylfibrinopeptide A (TYR-FPA) for radioimmunoassay.
    Urdén G
    Thromb Res; 1982 May; 26(4):289-96. PubMed ID: 7112517
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
    Mombelli G; Monotti R; Haeberli A; Straub PW
    Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of soluble fibrin oligomers in purified systems and in plasma.
    Alkjaersig N; Fletcher AP
    Biochem J; 1983 Jul; 213(1):75-83. PubMed ID: 6615433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence of release of fibrinopeptide A from fibrinogen molecules by thrombin or Atroxin.
    Meh DA; Siebenlist KR; Bergtrom G; Mosesson MW
    J Lab Clin Med; 1995 Mar; 125(3):384-91. PubMed ID: 7897305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinopeptide A (FPA) levels in atrial fibrillation and the effects of heparin administration.
    Uno M; Tsuji H; Sawada S; Toyoda T; Nakagawa M
    Jpn Circ J; 1988 Jan; 52(1):9-12. PubMed ID: 3361696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clearance of human desaminotyrosyl fibrinopeptide A from the rat circulation: role of kidney and proteolytic enzymes.
    Lane DA; Siodlak M; Thompson E; Allen-Mersh TG
    Thromb Res; 1982 Apr; 26(2):73-82. PubMed ID: 7051413
    [No Abstract]   [Full Text] [Related]  

  • 18. Reaction of plasmic degradation products of fibrinogen in the radioimmunoassay of human fibrinopeptide A.
    Budzynski AZ; Marder VJ; Sherry S
    Blood; 1975 Jun; 45(6):757-68. PubMed ID: 1168512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of 125I-labelled prolactin in the rabbit: effect of nephrectomy and prolactin infusion.
    Falconer IR; Vacek AT
    J Endocrinol; 1983 Dec; 99(3):369-77. PubMed ID: 6644231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clearance of human platelet factor 4 by liver and kidney: its alteration by heparin.
    Rucinski B; Knight LC; Niewiarowski S
    Am J Physiol; 1986 Oct; 251(4 Pt 2):H800-7. PubMed ID: 3766757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.